阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AZN 阿斯利康

盘前交易 05-08 06:03:35 EDT

182.52

-2.40

-1.30%

盘前180.41

-2.11-1.16%

06:01 EDT

最高184.37	最低181.03	成交量274.95万
今开184.37	昨收184.92	日振幅1.81%
总市值2,831亿	流通市值2,818亿	总股本15.51亿
成交额5.01亿	换手率0.18%	流通股本15.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"阿斯利康","latestPrice":182.52,"timestamp":1778184000000,"preClose":184.92,"halted":0,"volume":2749511,"hourTrading":{"tag":"盘前","latestPrice":180.41,"preClose":182.52,"latestTime":"06:01 EDT","volume":5546,"amount":999682.1397200001,"timestamp":1778234501359,"change":-2.11,"changeRate":-0.01156,"amplitude":0.00505},"delay":0,"changeRate":-0.012978585334198451,"floatShares":1544000000,"shares":1551000000,"eps":6.639935,"marketStatus":"盘前交易","change":-2.4,"latestTime":"05-08 06:03:35 EDT","open":184.37,"high":184.37,"low":181.03,"amount":501469453.75456,"amplitude":0.018062,"askPrice":180.48,"askSize":200,"bidPrice":180.41,"bidSize":50,"shortable":3,"etf":0,"ttmEps":6.639935,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778247000000},"marketStatusCode":1,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NYSE","adjPreClose":182.52,"dividendRate":0.0174,"preHourTrading":{"tag":"盘前","latestPrice":180.41,"preClose":182.52,"latestTime":"06:01 EDT","volume":5546,"amount":999682.1397200001,"timestamp":1778234501359,"change":-2.11,"changeRate":-0.01156,"amplitude":0.00505},"postHourTrading":{"tag":"盘后","latestPrice":182.52,"preClose":182.52,"latestTime":"19:45 EDT","volume":1355620,"amount":247427737.1922,"timestamp":1778197550400,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3511203515617733,"impliedVol":0.2804,"impliedVolPercentile":0.512},"requestUrl":"/m/hq/s/AZN/wiki","defaultTab":"wiki","newsList":[{"id":"2633794147","title":"多家药企高管生变：恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","AZNH","LU1057294990.SGD","LU0225771236.USD","SG9999001176.SGD","BK4588","LU0456855351.SGD","SG9999003800.SGD","BK4568","IE00BLSP4239.USD","LU0234572021.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4585","LU2456880835.USD","BK4533","LU0321505439.SGD","LU2417539215.USD","IE00BBT3K403.USD","600276","LU2462157665.USD","02196","LU0306807586.USD","LU0321505868.SGD","LU2236285917.USD","LU0122379950.USD","LU2237443978.SGD","SG9999013999.USD","SGXZ57979304.SGD","02142","LU0170899867.USD","SG9999011175.SGD","LU2237443382.USD","LU0058720904.USD","LU0868494617.USD","SG9999001176.USD","LU1066051498.USD","LU2237443549.SGD","LU0109394709.USD","SG9999002224.SGD","IE00B19Z3581.USD","BK4581","BK4534","IE0002270589.USD","06160","LU1883839398.USD","BK4599","01276","BK4592","LU0225284248.USD","LU1829250122.USD","600196","BK4007","LU1894683264.USD","688235","LU2237443895.HKD","PFE","SG9999002232.USD","BK4550","LU2237443622.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0320765992.SGD","LU2237443465.HKD","AZN","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1894683348.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633119830","title":"跨国药企业绩大爆发，集体加仓中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2633119830","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633119830?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:19","pubTimestamp":1778141940,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　2026年第一季度，全球制药巨头的业绩版图再度刷新。　　有券商医药行业分析师对21世纪经济报道记者表示，当前跨国药企的业绩已高度“超级重磅药化”，手握“王牌”产品足以决定公司的增长、估值乃至战略走向。默沙东与其他跨国药企一道，已将“加注中国创新”视为战略性防御与进攻并存的长期解法。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2026-05-07/doc-inhxahrf8322593.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-07/doc-inhxahrf8322593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0106261372.USD","LU2491050071.SGD","EURmain","LU2112291526.USD","LU0965508806.USD","LU0211331839.USD","LU1066051811.HKD","LU0234572021.USD","LU1162221912.USD","LU2023250504.SGD","MRK","LU0154236417.USD","LU1061106388.HKD","LU2361044949.HKD","LU0320765646.SGD","LU1069347547.HKD","IE0002141913.USD","SG9999015341.SGD","LU1941712264.USD","SG9999014542.SGD","IE00BLSP4239.USD","SG9999001176.USD","LU0098860793.USD","AZN","NVOH","NVOX","LU1023059063.AUD","LU2106854487.HKD","BK4534","BK4585","LU1093756325.SGD","LU1037948541.HKD","SG9999002232.USD","BK4588","LU2361044865.SGD","LU1093756168.USD","LU0208291251.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2023250843.SGD","SNY","LU0070302665.USD","LU0432979614.USD","LU2468319806.SGD","IE0009355771.USD","LU0861579265.USD","LU0980610538.SGD","LU0122379950.USD","LU1934455277.USD","LU0203345920.USD","LU0266013472.USD","LU0942090050.USD","IE00BBT3K403.USD","MEURmain","LU1934455863.HKD","LU0130102774.USD","BK4559","SG9999001176.SGD","LU0320765489.SGD","LU1585245621.USD","BK4532","LU0868494617.USD","BMY","LU0006306889.USD","LU1201861249.SGD","BK4533","LU2361045086.USD","BK4550","LU1116320901.HKD","LU1291159041.SGD","EUO","LU0965509101.SGD","LU2089984988.USD","BK4516","LU2461242641.AUD","BK4007","FXE","IE00B2B36J28.USD","SG9999002224.SGD","LU0238689110.USD","SG9999013999.USD","LU0203347892.USD","LU1699723380.USD","SG9999014567.USD","LU0477156953.USD","IE00BSNM7G36.USD","LU1116320737.USD","LU1989771016.USD","LU1571399168.USD","BK4599","LU1057294990.SGD","LU1941712348.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LLY","LU2357627491.SGD","LU1430594728.SGD","LU2360032135.SGD","LU1037948897.HKD","LU2491050154.USD","LU0859254822.USD","LU0265550359.USD","LU1929549753.HKD","LU1066051225.USD","LU1066053197.SGD","SG9999014575.USD","LU0985320562.USD","SG9999015358.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","LU2125154935.USD","IE000M9KFDE8.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU2324357040.USD","IE00BN8TJ469.HKD","LU0058720904.USD","LU0265550946.USD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU2491049909.HKD","LU1917777945.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU0965509010.AUD","LU0965509283.SGD","LU1934455194.USD","LU1989772840.SGD","LU0130517989.USD","LU2125154778.USD","LU1974910355.USD","NVS","LU0868494708.USD","LU1989772923.USD","NVO","LU1066051498.USD","SG9999014559.SGD","LU1035773651.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632260556","title":"诚益生物冲刺港股：年亏损4460万美元 业务深度绑定阿斯利康","url":"https://stock-news.laohu8.com/highlight/detail?id=2632260556","media":"雷递网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632260556?lang=zh_cn&edition=full","pubTime":"2026-05-03 10:35","pubTimestamp":1777775725,"startTime":"0","endTime":"0","summary":"诚益生物开曼有限公司（简称：“诚益生物”）日前更新招股书，准备在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260503/6391340131178578595887971.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260503/6391340131178578595887971.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33522/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU0320765992.SGD","LU2237443465.HKD","LU2237443622.USD","LU2237443895.HKD","LU2237443978.SGD","LU2236285917.USD","LU0058720904.USD","BK4588","LU0109394709.USD","LU2417539215.USD","VXUS","BK4568","LU2237443382.USD","LU2462157665.USD","BK4585","LU2237443549.SGD","LU2456880835.USD","AZN","LU0289739699.SGD","LU1829250122.USD","BK4007","IE00B3T34201.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632619163","title":"伯恩斯坦将阿斯利康目标价从20500便士下调至18600便士。","url":"https://stock-news.laohu8.com/highlight/detail?id=2632619163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632619163?lang=zh_cn&edition=full","pubTime":"2026-05-01 19:09","pubTimestamp":1777633776,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZN.UK","AZNH","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632504618","title":"阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2632504618","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632504618?lang=zh_cn&edition=full","pubTime":"2026-05-01 16:14","pubTimestamp":1777623240,"startTime":"0","endTime":"0","summary":"在乳腺癌候选药物未能在一项关键的咨询委员会投票中获得支持后，英国制药集团阿斯利康表示，该公司将继续与美国监管机构合作，对该药物进行审查。该公司周四晚间表示，美国食品药品管理局的肿瘤药物咨询委员会以6比3的投票结果，对乳腺癌治疗候选药物camizestrant的获益-风险评估给出否定性意见。阿斯利康的股价在周五开盘交易中下跌了约1.8%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-01/doc-inhwktza5459710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZNH","LU0058720904.USD","LU1829250122.USD","IE00B3T34201.USD","AZN.UK","LU0109394709.USD","LU2237443549.SGD","LU0889565916.HKD","LU2237443622.USD","LU2237443382.USD","AZN","LU2462157665.USD","LU2237443978.SGD","BK4588","BK4007","LU2237443465.HKD","LU0320765992.SGD","LU2417539215.USD","LU0289739699.SGD","LU2237443895.HKD","LU2456880835.USD","LU2236285917.USD","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161357099","title":"FDA顾问委员会推荐阿斯利康Truqap用于PTEN缺陷型转移性激素敏感性前列腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1161357099","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161357099?lang=zh_cn&edition=full","pubTime":"2026-05-01 05:49","pubTimestamp":1777585759,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局顾问委员会近日对阿斯利康制药旗下抗癌药物Truqap给予积极推荐，支持其用于治疗PTEN缺陷型转移性激素敏感性前列腺癌患者。该研究证实，在PTEN缺失的转移性激素敏感性前列腺癌患者中，Truqap治疗方案能显著延长影像学无进展生存期，为这类特定人群提供了新的精准治疗选择。FDA通常遵循顾问委员会的建议，但最终决定仍待官方审评。若获批，Truqap将成为首个针对PTEN缺陷型mHSPC的靶向疗法，填补当前治疗格局中的重要空白。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0011850046.USD","LU0969580561.USD","AZNH","LU0972486137.USD","IE00BFTCPJ56.SGD","LU1104425308.USD","LU0432979614.USD","LU1061106388.HKD","LU0499090636.EUR","LU0708994859.HKD","LU0823399737.USD","LU0784385170.HKD","LU0859254822.USD","LU1196032939.SGD","LU2089283258.USD","LU1003076772.USD","LU1496350502.SGD","LU0738911758.USD","LU0997586432.USD","LU0784385840.USD","LU0949170426.SGD","IE0034235188.USD","LU0964806797.USD","LU0058720904.USD","LU1880407132.USD","LU0114720955.EUR","LU1989772923.USD","LU1119994496.HKD","LU2112291526.USD","LU0047473722.EUR","LU1019634622.SGD","LU1923622614.USD","SG9999001176.USD","LU0949170772.SGD","LU1015430645.USD","LU2355687059.USD","LU0640478417.SGD","LU0211326839.USD","BK5011","IE00B4R5TH58.HKD","LU0661504455.SGD","LU0882574055.USD","LU1496350171.SGD","LU2091194634.USD","LU0310799852.SGD","LU0211328371.USD","LU0920783379.SGD","LU1153585028.USD","AZN","LU0575583348.USD","LU2089984988.USD","LU0203347892.USD","LU0920840948.USD","LU1261432733.SGD","LU0029864427.USD","LU1267930227.SGD","LU0052756011.USD","LU0047473722.SGD","LU0310800379.SGD","LU1880407215.USD","LU1023059063.AUD","IE00BKPKM643.USD","LU2324357040.USD","SG9999013999.USD","LU1481599808.USD","LU2089284900.SGD","LU1078025761.USD","LU0266013472.USD","LU0122379950.USD","LU1273509221.SGD","LU0976567544.SGD","IE00B3T34201.USD","LU0390134368.USD","LU1989771016.USD","LU2125909247.SGD","LU0310800965.SGD","LU0887340254.USD","LU0827474353.SGD","LU1051770623.HKD","LU0545039389.USD","LU1153584641.USD","LU2279689827.SGD","LU0345777147.USD","LU1291159041.SGD","LU2293690082.USD","LU0960981461.USD","IE0009355771.USD","LU1057294990.SGD","LU2114397693.USD","LU1983299246.USD","LU0128525929.USD","LU1301847155.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU0857590862.USD","AZN.UK","LU1267930813.SGD","SG9999001176.SGD","LU0889566641.SGD","LU1267930573.SGD","LU1323610961.USD","LU2539964713.USD","LU0963555726.SGD","LU1814569148.SGD","LU2125909593.SGD","LU2023251221.USD","LU2357627491.SGD","IE00B2B36J28.USD","LU0171293334.USD","LU0211326755.USD","LU1084165304.USD","LU0158827948.USD","LU0496365809.HKD","LU0557290698.USD","LU0757432116.USD","LU0784383803.USD","LU0889565080.SGD","LU0553294199.USD","LU1019632923.USD","LU0128525689.USD","LU0957799991.USD","LU1267930490.SGD","LU0211327993.USD","LU1487256676.USD","LU0823416689.USD","LU0784384876.USD","IE0002141913.USD","LU2108987350.USD","LU2468319806.SGD","LU0792757196.USD","LU0203345920.USD","LU0526926950.USD","LU1003077747.HKD","LU1481600234.SGD","LU0289739699.SGD","LU1170363599.USD","SGXZ57979304.SGD","LU2293690249.USD","IE00BJJMRZ35.SGD","LU1046234339.USD","LU0997586515.USD","LU0345777659.USD","LU1989772840.SGD","LU2433249047.HKD","LU0077335932.USD","LU1064927863.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171095508","title":"阿斯利康行使选择权 根据协议条款向Pintree Therapeutics支付2500万美元交割款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1171095508","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171095508?lang=zh_cn&edition=full","pubTime":"2026-04-30 07:03","pubTimestamp":1777503805,"startTime":"0","endTime":"0","summary":"根据双方达成的协议条款，阿斯利康制药行使选择权，此举触发了其向Pintree Therapeutics支付一笔高达2500万美元的选择权交割款项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0827474353.SGD","LU0757432116.USD","LU0708994859.HKD","LU1196032939.SGD","LU1880407215.USD","LU1015430645.USD","LU1481600234.SGD","AZNH","LU1153584641.USD","LU0211326755.USD","LU0128525689.USD","LU0499090636.EUR","LU1153585028.USD","LU2324357040.USD","LU0114720955.EUR","LU1880407132.USD","LU0011850046.USD","LU1989772840.SGD","LU0640478417.SGD","LU1003077747.HKD","LU1078025761.USD","SG9999001176.SGD","AZN","LU0792757196.USD","LU0029864427.USD","AZN.UK","LU1119994496.HKD","LU0058720904.USD","LU2125909593.SGD","LU1989771016.USD","LU0972486137.USD","LU0047473722.EUR","IE00B2B36J28.USD","LU0266013472.USD","LU0390134368.USD","LU0557290698.USD","LU1496350502.SGD","LU2125909247.SGD","LU2089283258.USD","LU2114397693.USD","IE00B3T34201.USD","LU0211327993.USD","LU2089284900.SGD","SG9999013999.USD","LU0960981461.USD","LU1481599808.USD","LU0211326839.USD","LU0976567544.SGD","BK5011","LU1989772923.USD","LU1046234339.USD","LU1023059063.AUD","LU0310799852.SGD","LU0345777147.USD","LU2279689827.SGD","IE0009355771.USD","LU1170363599.USD","LU1273509221.SGD","LU2539964713.USD","LU1051770623.HKD","LU2023251221.USD","IE00B4R5TH58.HKD","IE0034235188.USD","LU0289739699.SGD","IE0002141913.USD","LU1104425308.USD","LU1496350171.SGD","SG9999001176.USD","LU2133065610.SGD","LU2433249047.HKD","LU0047473722.SGD","LU0575583348.USD","LU0496365809.HKD","LU2293690249.USD","LU0310800965.SGD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU0077335932.USD","LU2293690082.USD","LU2091194634.USD","LU1003076772.USD","LU1084165304.USD","LU0784383803.USD","LU1814569148.SGD","LU0857590862.USD","LU1301847155.USD","LU0122379950.USD","LU0784385840.USD","LU0211328371.USD","LU1019632923.USD","LU2112291526.USD","LU0203345920.USD","LU1923622614.USD","IE00BJT1NW94.SGD","LU2108987350.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0920783379.SGD","LU0920840948.USD","LU0889565080.SGD","LU0661504455.SGD","LU0882574055.USD","LU1064927863.SGD","LU0969580561.USD","LU0310800379.SGD","LU1487256676.USD","LU0823399737.USD","LU0203347892.USD","LU1019634622.SGD","LU0957799991.USD","LU0964806797.USD","LU2089984988.USD","LU0997586432.USD","LU1267930813.SGD","LU0949170426.SGD","LU1291159041.SGD","LU0545039389.USD","LU1261432733.SGD","LU2357627491.SGD","LU0859254822.USD","LU1267930227.SGD","LU0738911758.USD","LU0526926950.USD","LU0158827948.USD","LU2355687059.USD","IE00BKPKM643.USD","LU0887340254.USD","LU1061106388.HKD","LU0823416689.USD","LU1267930490.SGD","LU0345777659.USD","LU0784385170.HKD","LU0432979614.USD","LU1983299246.USD","LU1267930573.SGD","LU0997586515.USD","LU1057294990.SGD","LU0889566641.SGD","LU0171293334.USD","LU0784384876.USD","LU0128525929.USD","LU0553294199.USD","LU0949170772.SGD","LU0963555726.SGD","LU2468319806.SGD","LU0052756011.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159873248","title":"阿斯利康宣布3亿英镑对英投资，涵盖去年暂停的剑桥研发基地后续建设","url":"https://stock-news.laohu8.com/highlight/detail?id=1159873248","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159873248?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:51","pubTimestamp":1777463500,"startTime":"0","endTime":"0","summary":"阿斯利康制药首席执行官帕斯卡尔·索里奥特今日宣布，公司将对英国投资3亿英镑。此项投资计划包含完成去年一度暂停的剑桥研发基地建设项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN.UK","LU1880407132.USD","LU2125909593.SGD","LU2279689827.SGD","LU1267930813.SGD","LU1019634622.SGD","LU0784384876.USD","LU1481599808.USD","LU1046234339.USD","LU0784383803.USD","LU0310800379.SGD","LU0310800965.SGD","LU1261432733.SGD","LU0345777147.USD","LU0889565080.SGD","LU2324357040.USD","LU1814569148.SGD","LU1015430645.USD","LU2023251221.USD","LU2133065610.SGD","LU2089284900.SGD","LU0203347892.USD","LU1923622614.USD","LU1153584641.USD","LU1983299246.USD","LU0784385170.HKD","LU1119994496.HKD","LU1989772840.SGD","LU0964806797.USD","LU0997586515.USD","LU0920840948.USD","LU0949170772.SGD","LU2108987350.USD","LU0882574055.USD","LU0960981461.USD","LU1267930573.SGD","LU1153585028.USD","LU2355687059.USD","LU0557290698.USD","LU0128525929.USD","LU0553294199.USD","LU0203345920.USD","LU0289739699.SGD","LU0997586432.USD","LU1051770623.HKD","LU1084165304.USD","LU1880407215.USD","LU0114720955.EUR","LU0738911758.USD","LU0310799852.SGD","LU1481600234.SGD","LU0211327993.USD","LU1291159041.SGD","LU0827474353.SGD","LU0823399737.USD","LU1496350502.SGD","LU1989771016.USD","LU0920783379.SGD","LU1989772923.USD","LU0047473722.SGD","LU0526926950.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1487256676.USD","LU1301847155.USD","LU0545039389.USD","LU0496365809.HKD","LU0857590862.USD","LU0757432116.USD","LU2433249047.HKD","LU0047473722.EUR","LU1496350171.SGD","LU0708994859.HKD","LU0972486137.USD","SG9999013999.USD","IE00BKPKM643.USD","IE0009355771.USD","IE0002141913.USD","LU0889566641.SGD","LU0266013472.USD","LU0499090636.EUR","LU1323610961.USD","LU0052756011.USD","LU1003077747.HKD","LU1196032939.SGD","LU0345777659.USD","LU1003076772.USD","LU0122379950.USD","LU1267930490.SGD","LU0128525689.USD","LU1273509221.SGD","SG9999001176.USD","LU0963555726.SGD","LU2089283258.USD","LU1061106388.HKD","LU0077335932.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0575583348.USD","LU0887340254.USD","LU2112291526.USD","LU0171293334.USD","AZNH","SG9999001176.SGD","IE00B3T34201.USD","LU1064927863.SGD","LU1019632923.USD","IE0034235188.USD","LU0949170426.SGD","IE00BFTCPJ56.SGD","LU0390134368.USD","LU2539964713.USD","LU0859254822.USD","LU0640478417.SGD","LU0029864427.USD","LU2114397693.USD","LU0158827948.USD","LU1023059063.AUD","LU0957799991.USD","LU1078025761.USD","LU2293690082.USD","LU1104425308.USD","LU0211326755.USD","LU0823416689.USD","LU0969580561.USD","LU0011850046.USD","LU0211326839.USD","LU0211328371.USD","LU1170363599.USD","LU2089984988.USD","LU2468319806.SGD","LU0976567544.SGD","LU2357627491.SGD","SGXZ57979304.SGD","LU1267930227.SGD","LU2125909247.SGD","LU2091194634.USD","IE00BJJMRZ35.SGD","LU0661504455.SGD","BK5011","LU2293690249.USD","LU0792757196.USD","LU0432979614.USD","LU1057294990.SGD","LU0784385840.USD","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125435733","title":"阿斯利康CEO：英美医药协议将惠及患者，提升药物可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1125435733","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125435733?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:35","pubTimestamp":1777462524,"startTime":"0","endTime":"0","summary":"阿斯利康制药首席执行官帕斯卡尔·索里奥表示，近期达成的美国与英国之间的医药合作协议，将有效改善患者的药物获取渠道。索里奥在媒体电话会议上指出，这一合作框架有望简化新药审批流程，并促进创新疗法更快速地惠及有需要的患者群体。他强调，加强国际协作对于应对全球健康挑战至关重要，而此项协议正是推动医药领域进步的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211326755.USD","LU1078025761.USD","LU0345777147.USD","LU0575583348.USD","LU2433249047.HKD","LU0784383803.USD","LU2089284900.SGD","LU0345777659.USD","LU0128525929.USD","LU0859254822.USD","LU2293690249.USD","LU0960981461.USD","LU2133065610.SGD","LU0011850046.USD","SGXZ57979304.SGD","LU0823399737.USD","LU1487256676.USD","IE00BKPKM643.USD","LU0757432116.USD","LU2293690082.USD","LU0949170772.SGD","LU1196032939.SGD","LU2091194634.USD","LU0266013472.USD","IE00B2B36J28.USD","LU1983299246.USD","LU2357627491.SGD","LU1003076772.USD","SG9999001176.SGD","LU0738911758.USD","LU2125909593.SGD","LU0390134368.USD","LU1267930573.SGD","LU0171293334.USD","LU2468319806.SGD","LU1015430645.USD","LU0792757196.USD","LU1153585028.USD","LU1019634622.SGD","LU0203347892.USD","LU1923622614.USD","AZN","LU0553294199.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0997586432.USD","LU0949170426.SGD","LU0432979614.USD","LU0052756011.USD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU0857590862.USD","IE0034235188.USD","LU0211328371.USD","LU1880407132.USD","LU2279689827.SGD","LU0310800379.SGD","LU0029864427.USD","LU0203345920.USD","LU0496365809.HKD","LU1880407215.USD","SG9999013999.USD","LU1003077747.HKD","LU1989772840.SGD","LU0058720904.USD","LU1119994496.HKD","LU0827474353.SGD","LU0640478417.SGD","LU0661504455.SGD","LU0047473722.EUR","LU0122379950.USD","LU2324357040.USD","LU0823416689.USD","BK5011","LU1104425308.USD","LU2355687059.USD","LU0969580561.USD","LU1989772923.USD","LU0889565080.SGD","LU1496350502.SGD","IE00B4R5TH58.HKD","LU0964806797.USD","IE0002141913.USD","LU1481600234.SGD","LU0310799852.SGD","LU2114397693.USD","LU1019632923.USD","LU0128525689.USD","LU1051770623.HKD","LU0158827948.USD","AZNH","LU0545039389.USD","LU1267930227.SGD","AZN.UK","LU0957799991.USD","LU1061106388.HKD","LU1989771016.USD","LU0972486137.USD","LU2112291526.USD","LU1267930813.SGD","LU1046234339.USD","LU1291159041.SGD","LU0211326839.USD","LU0882574055.USD","LU1153584641.USD","LU1023059063.AUD","LU0289739699.SGD","LU1301847155.USD","LU1170363599.USD","SG9999001176.USD","LU2125909247.SGD","LU1261432733.SGD","LU0784385840.USD","LU1057294990.SGD","LU0997586515.USD","LU0310800965.SGD","LU1267930490.SGD","LU1084165304.USD","LU0077335932.USD","LU2539964713.USD","IE00B3T34201.USD","LU1496350171.SGD","LU0784385170.HKD","LU2023251221.USD","LU0920840948.USD","LU0887340254.USD","LU1273509221.SGD","LU2089984988.USD","LU0784384876.USD","LU0920783379.SGD","LU0708994859.HKD","LU0526926950.USD","LU0499090636.EUR","LU0976567544.SGD","LU1814569148.SGD","LU1481599808.USD","LU0557290698.USD","IE0009355771.USD","LU0963555726.SGD","LU0211327993.USD","LU0047473722.SGD","LU1323610961.USD","LU0889566641.SGD","LU1064927863.SGD","LU2089283258.USD","LU2108987350.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631567485","title":"阿斯利康(AZN.US)哮喘三联疗法获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2631567485","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631567485?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:28","pubTimestamp":1777451308,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月28日，阿斯利康宣布布地格福吸入气雾剂获得FDA批准用于维持治疗12岁及以上哮喘患者。布地格福是阿斯利康开发的一款固定剂量三联疗法，包含布地奈德、格隆溴铵、福莫特罗三种药物活性成分。FDA此次批准是基于两项III期研究的积极结果。结果显示，相较于Symbicort组，布地格福吸入气雾剂组患者的1秒内用力呼气量显著改善，并且重度哮喘恶化发生率显著降低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1829250122.USD","LU2462157665.USD","BK4568","LU0320765992.SGD","LU0109394709.USD","LU2236285917.USD","BK4588","AZN","LU2237443622.USD","LU0289739699.SGD","LU0889565916.HKD","LU2237443549.SGD","BK4007","BK4585","LU2237443895.HKD","LU2456880835.USD","LU2237443465.HKD","LU2237443382.USD","LU2417539215.USD","LU0058720904.USD","LU2237443978.SGD","IE00B3T34201.USD","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631561829","title":"明星抗癌药需求强劲，阿斯利康Q1营收和利润均超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2631561829","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631561829?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:10","pubTimestamp":1777446600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，受明星抗癌药物需求的推动，阿斯利康第一季度利润增长超预期。财报显示，阿斯利康第一季度总营收152.88亿美元，同比增长8%，超出市场预期；调整后每股收益为 2.58 美元，高于分析师预期的 2.55 美元。继 2025 年股价大幅上涨 32% 后，阿斯利康的股价今年至今基本持平。虽然抗癌药物一直是阿斯利康成功的关键，但其针对心血管和代谢疾病的产品组合销售额在第一季度有所下降。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436063.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"明星抗癌药需求强劲，阿斯利康Q1营收和利润均超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630369561","title":"阿斯利康(AZN.US)“双免疫治疗”新适应症在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2630369561","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630369561?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:54","pubTimestamp":1777280053,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月27日，阿斯利康宣布，中国国家药品监督管理局已正式批准英飞凡联合英卓凡用于晚期或不可切除的肝细胞癌成人患者的一线治疗。本次新适应症的批准是基于全球 III 期 HIMALAYA 研究及中国队列的积极结果。数据显示，STRIDE 方案组与度伐利尤单抗单药组的三级及以上治疗相关不良事件发生率分别为 24.1% 和 12.4%，均低于索拉非尼组的 40.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0058720904.USD","IPOS","LU2237443382.USD","LU2237443978.SGD","LU2237443465.HKD","BK4588","LU0109394709.USD","AZN","IE00B3T34201.USD","LU2456880835.USD","LU0320765992.SGD","BK4568","LU2237443895.HKD","LU2236285917.USD","LU2417539215.USD","LU0889565916.HKD","BK4007","LU2462157665.USD","BK4585","LU2237443549.SGD","LU1829250122.USD","LU0289739699.SGD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629892730","title":"从“癌种攻坚”到“生态引领”： 阿斯利康肿瘤防治的中国答卷","url":"https://stock-news.laohu8.com/highlight/detail?id=2629892730","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629892730?lang=zh_cn&edition=full","pubTime":"2026-04-21 16:33","pubTimestamp":1776760380,"startTime":"0","endTime":"0","summary":"癌症长期位居全球第二大致死原因，而中国以全球最高的新发和死亡人数，站在抗癌最前线。行业正直面一个关键问题：如何通过真正的科学突破，持续降低死亡负担，改善患者生存期与生活质量。这从来不是一句空泛的口号，而是一场必须打赢的硬仗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604213712331011.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604213712331011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2237443382.USD","LU2237443549.SGD","LU1829250122.USD","LU0889565916.HKD","AZN","LU0109394709.USD","BK4007","LU2236285917.USD","BK4585","IE00B3T34201.USD","BK4568","BK4588","LU2237443895.HKD","LU0289739699.SGD","LU2237443622.USD","LU2417539215.USD","LU0320765992.SGD","LU2462157665.USD","LU2237443978.SGD","LU2456880835.USD","LU0058720904.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625990082","title":"大摩：将阿斯利康目标价上调至16500便士","url":"https://stock-news.laohu8.com/highlight/detail?id=2625990082","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625990082?lang=zh_cn&edition=full","pubTime":"2026-04-08 14:27","pubTimestamp":1775629621,"startTime":"0","endTime":"0","summary":"摩根士丹利将阿斯利康目标股价从16000便士上调至16500便士。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260408/32130641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625027964","title":"全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2625027964","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625027964?lang=zh_cn&edition=full","pubTime":"2026-04-08 07:05","pubTimestamp":1775603119,"startTime":"0","endTime":"0","summary":"｜2026年4月8日星期三｜NO.1清明假期广东旅游收入超百亿元“广东发布”微信公众号4月7日消息，据初步测算，2026年清明假期三天（4月4日至6日），广东接待游客1985.1万人次，实现旅游收入104.3亿元。点评：百亿文旅收入印证广东内需韧性、消费活力、湾区磁吸效应，为一季度经济收官、二季度内需扩容打下坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604083696940526.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604083696940526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","LU2237443978.SGD","LU2237443465.HKD","LU2417539215.USD","LU2236285917.USD","LU2237443895.HKD","159983","LU2237443382.USD","LU2237443622.USD","ROBO","BK4588","LU0058720904.USD","BK4585","161726","BK4007","LU0109394709.USD","LU0289739699.SGD","LU2462157665.USD","LU2456880835.USD","LU0889565916.HKD","LU2237443549.SGD","AZN","IE00B3T34201.USD","BK4568","BK4581","LU0320765992.SGD","LU1829250122.USD","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623856985","title":"核药“热战”：阿斯利康为何押注广州？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623856985","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623856985?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:47","pubTimestamp":1774954020,"startTime":"0","endTime":"0","summary":"继ADC（抗体偶联药物）之后，核药正在成为全球生物医药市场最炙手可热的赛道。诺华的Pluvicto（针对前列腺癌细胞的核药）2025年全年销售额达19.94亿美元，连续两年全球销售额同比增长42%，是全球首个突破10亿美元的核药。这验证了核药的商业潜力，短短两年，跨国药企在核药领域砸下数百亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690600660.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690600660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2237443382.USD","LU2237443549.SGD","LU1829250122.USD","LU0889565916.HKD","AZN","LU0109394709.USD","BK4007","LU2236285917.USD","BK4585","IE00B3T34201.USD","BK4568","BK4588","LU2237443895.HKD","LU0289739699.SGD","LU2237443622.USD","LU2417539215.USD","LU0320765992.SGD","LU2462157665.USD","LU2237443978.SGD","LU2456880835.USD","LU0058720904.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623154273","title":"阿斯利康(AZN)罕见病创新药在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2623154273","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623154273?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:55","pubTimestamp":1774864518,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康(AZN)宣布，中国国家药品监督管理局已正式批准硫酸氢司美替尼胶囊（商品名：科赛优），用于3岁及3岁以上伴有症状、无法手术的丛状神经纤维瘤（PN）的1型神经纤维瘤病（NF1）儿童及成人患者的治疗。这是目前国内首个且唯一获批用于3岁及3岁以上该患者人群的治疗药物。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298501","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU0058720904.USD","LU0320765992.SGD","LU2462157665.USD","BK4588","BK1161","LU2456880835.USD","BK4585","LU2417539215.USD","IE00B3T34201.USD","LU0889565916.HKD","BK4568","LU1829250122.USD","06978","LU0289739699.SGD","BK4007","LU0109394709.USD","159992","AZN","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623124397","title":"阿里健康与阿斯利康达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2623124397","media":"新华财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623124397?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:27","pubTimestamp":1774859228,"startTime":"0","endTime":"0","summary":"新华财经北京3月30日电（记者沈寅飞）记者从阿里健康获悉，近日，阿斯利康全球商业副总裁SandraDisse，阿斯利康中国助理副总裁、生物制药业务早期管线负责人吴中一及阿斯利康中国零售团队到访杭州，走进阿里健康，围绕数智化健康生态与医学赋能下的服务模式展开深度交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303688715385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1502","BK1189","LU2236285917.USD","BK1615","BK1589","LU2462157665.USD","LU2417539215.USD","AZN","BK1515","BK1617","BK1584","BK4585","LU0289739699.SGD","LU2456880835.USD","BK1247","BK4568","BK1610","BK4588","BK4007","LU0320765992.SGD","LU0058720904.USD","BK1142","BK1591","LU0109394709.USD","BK1571","LU0889565916.HKD","LU1829250122.USD","00241","IE00B3T34201.USD","BK1501"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623539793","title":"科赛优®在华获批用于治疗伴有症状、无法手术的丛状神经纤维瘤的1型神经纤维瘤病（NF1-PN）儿童及成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2623539793","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623539793?lang=zh_cn&edition=full","pubTime":"2026-03-30 15:46","pubTimestamp":1774856760,"startTime":"0","endTime":"0","summary":"成为国内首个且唯一*获批用于3岁及3岁以上该患者人群的治疗药物 上海2026年3月30日 /美通社/ -- 阿斯利康宣布，中国国家药品监督管理局已正式批准科赛优，一种选择性、口服MEK抑制剂，用于3岁及3岁以上伴有症状、无法手术的丛状神经纤维瘤的1型神经纤维瘤病儿童及成人患者的治疗[1]。司美替尼已在美国、欧盟、日本、中国及其他国家/地区获批，用于治疗特定伴有症状且无法手术切除PN的 NF1 儿童患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4922084_ZH22084_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1829250122.USD","BK4588","ORR","LU0058720904.USD","BK4007","LU0889565916.HKD","LU0289739699.SGD","BK4096","LU2417539215.USD","LU0320765992.SGD","BK4585","LU2462157665.USD","AZN","LU0109394709.USD","LU2456880835.USD","PN","BK4568","IE00B3T34201.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623369335","title":"加科思-B(01167)收到阿斯利康就泛KRAS抑制剂JAB-23E73订立的许可及合作协议项下的1亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2623369335","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623369335?lang=zh_cn&edition=full","pubTime":"2026-03-30 08:02","pubTimestamp":1774828968,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B(01167)发布公告，内容有关北京加科思新药研发有限公司(北京加科思，本集团的非全资附属公司)与AstraZeneca AB(阿斯利康)订立了许可与合作协议。本公司的附属公司北京加科思就其订立的许可及合作协议，已收到阿斯利康支付的1亿美元的首付款。该首付款的到账，进一步充盈了本集团的现金储备，也将为本集团后续创新肿瘤疗法管线研发的推进提供助力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","LU0058720904.USD","01167","BK1574","AZN","LU2236285917.USD","BK4585","LU1829250122.USD","BK1161","IE00B3T34201.USD","LU0109394709.USD","LU2417539215.USD","BK4007","LU2456880835.USD","LU0289739699.SGD","LU2462157665.USD","LU0889565916.HKD","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astrazeneca.com","stockEarnings":[{"period":"1week","weight":-0.0259},{"period":"1month","weight":-0.0911},{"period":"3month","weight":-0.0544},{"period":"6month","weight":0.079},{"period":"1year","weight":0.3024},{"period":"ytd","weight":-0.0073}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"阿斯利康股份有限公司于1992年6月17日根据1985年《公司法》在英格兰和威尔士注册成立。该公司是在1993年将Imperial化学工业公司的制药、农化和特种化学品业务分拆时成立的。1999年，公司出售了特种化学品业务。同样在1999年，该公司与瑞典Astra公司合并。2000年，该公司将农化业务分拆，并将其与诺华公司的同类业务合并，成立了一家新的公司Syngenta AG。2007年，集团收购了位于美国的生物制剂和疫苗企业MedImmune。2021年，集团收购了位于美国的罕见病企业Alexion。","yearOnYearQuotes":[{"month":1,"riseRate":0.515152,"avgChangeRate":0.001662},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.012868},{"month":3,"riseRate":0.545455,"avgChangeRate":0.025511},{"month":4,"riseRate":0.636364,"avgChangeRate":0.028791},{"month":5,"riseRate":0.515152,"avgChangeRate":0.007702},{"month":6,"riseRate":0.454545,"avgChangeRate":0.018334},{"month":7,"riseRate":0.606061,"avgChangeRate":-0.002513},{"month":8,"riseRate":0.484848,"avgChangeRate":0.004788},{"month":9,"riseRate":0.545455,"avgChangeRate":0.001232},{"month":10,"riseRate":0.545455,"avgChangeRate":0.015301},{"month":11,"riseRate":0.515152,"avgChangeRate":0.003764},{"month":12,"riseRate":0.545455,"avgChangeRate":0.007464}],"exchange":"NYSE","name":"阿斯利康","nameEN":"AstraZeneca PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿斯利康,AZN,阿斯利康股票,阿斯利康股票老虎,阿斯利康股票老虎国际,阿斯利康行情,阿斯利康股票行情,阿斯利康股价,阿斯利康股市,阿斯利康股票价格,阿斯利康股票交易,阿斯利康股票购买,阿斯利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}